On May 06, 2026, CVS reported earnings of 2.57 USD per share (EPS) for Q1 26, beating the estimate of 2.21 USD, resulting in a 15.80% surprise. Revenue reached 100.43 billion, compared to an expected 96.05 billion, with a 4.56% difference. The market reacted with a +7.65% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 20 analysts forecast an EPS of 1.83 USD, with revenue projected to reach 101.16 billion USD, implying an decrease of -28.79% EPS, and increase of 0.73% in Revenue from the last quarter.